Tag Archives: salix pharmaceuticals

August, 2018

March, 2015

  • 16 March

    Valeant Raises its Offer to Acquire Salix

    After Endo International offered a rival bid, Valeant Pharmaceuticals International announced that it has raised its offer for gastrointestinal drugmaker Salix Pharmaceuticals. The companies announced that they have entered into an amendment to their agreement and plan merger. Valeant has increased its offer price to acquire all the outstanding common …

  • 11 March

    Endo Threatens Valeant’s Deal with Competing Bid for Salix Pharmaceuticals

    Today, Endo International plc confirmed that it has made a takeover bid for Salix Pharmaceuticals Ltd., looking to interrupt Valeant’s plans to acquire the gastrointestinal drugmaker. Endo said that it has submitted a proposal to the Board of Directors of Salix to acquire all of the outstanding shares of common …

February, 2015

  • 23 February

    Valeant to Buy Salix Pharmaceuticals for $10.1 Billion

    Valeant Pharmaceuticals International Inc. announced that it is buying Salix Pharmaceuticals Ltd. for $10.1 billion. Valeant is paying $158 a share for Salix, gaining a portfolio of gastrointestinal (GI) drugs and a strong near-term pipeline of innovative, new assets. The deal values Salix at about $14.5 billion including net debt …